1. Murdaca G, Spanò F, Puppo F. Selective TNF-alpha inhibitor-induced injection site reactions. Expert Opin Drug Saf. 2013;12:187–93.
2. Zeltser R, Valle L, Tanck C, Holyst MM, Ritchlin C, Gaspari AA. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein. Arch Dermatol. 2001;137:893–9.
3. United States Food and Drug Administration. Questions and answers on FDA’s Adverse Event Reporting System (FAERS). In: FDA adverse event reporting system (FAERS). 2018. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm. Accessed 3 Jan 2019.
4. United States Food and Drug Administration. FDA adverse event reporting system (FAERS) quarterly data extract files. https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html. Accessed 7 Jan 2019.
5. United States Food and Drug Admionistration. FDA adverse event resporting system (FAERS) public dashboard. https://fis.fda.gov/sense/app/d10be6bb-494e-4cd2-82e4-0135608ddc13/sheet/7a47a261-d58b-4203-a8aa-6d3021737452/state/analysis. Accessed 7 Jan 2019.